Global Demand for Venous Stent Devices Is Reach A Industry Valuation of US$ 2.44 Billion by 2032

Global demand for venous stent devices is valued at US$ 1.08 billion in 2022. The market for venous stents is predicted to increase rapidly at a CAGR of 8.5% during the forecast period and reach a market valuation of US$ 2.44 billion by the year 2032.

Download Free Sample Copy of This Report:

https://www.factmr.com/connectus/sample?flag=S&rep_id=7879

Venous stent technologies are classified into Iliac vein stent technologies and Wallstent technologies. Revenue from Wallstent technologies is expected to increase at a higher CAGR of 9% during the next 10 years. The purpose of Wallstent technology is to treat a constricted vein in the upper pelvic area that extends to the groyne area (iliofemoral vein). The Wallstent system usually consists of two parts: a stent composed of braided metallic (elgiloy) wire and a catheter device for over-the-wire stent delivery.

Competitive Landscape

Major venous stent companies are concentrated on launching upgraded stents and innovation in technologies to accelerate sales growth.

• The Medtronic venous stent namely "Abre venous self-expanding stent system" has been approved by the US Food and Drug Administration (FDA) for use in October 2020. When a patient has symptomatic deep venous obstruction, also known as iliofemoral venous outflow obstruction, this device is suggested for treatment.

• The "S.M.A.R.T. RADIANZ Vascular Stent System" from Cordis, a self-expanding stent specially developed for radial peripheral operations, obtained FDA approval in March 2022. The S.M.A.R.T. RADIANZ Vascular Stent System makes it easier to accurately and effectively insert stents in the superficial femoral (SFA) and iliac arteries.

Share Your Requirements & Get Customized Reports:

https://www.factmr.com/connectus/sample?flag=RC&rep_id=7879

Key Companies Profiled:

• Becton, Dickinson Company
• Boston Scientific Corporation
• Cook Medical LLC
• Gore Medical
• Jotec GmbH
• OptiMed Medizinische Instrumente GmbH

"Rising in Demand for Venous stent Industry"

The demand for venous stents is rising due to the increasing prevalence of chronic venous diseases, such as deep vein thrombosis (DVT) and varicose veins. The growing awareness about the availability of minimally invasive treatments for these conditions is also driving the demand for venous stents.

Additionally, technological advancements in the design and manufacturing of venous stents are making them more effective and efficient, which is further boosting their demand. Furthermore, the increasing number of clinical trials and research studies to evaluate the safety and efficacy of venous stents is also contributing to their rising demand.

Full Access to this Report Is Available:

https://www.factmr.com/checkout/7879

Key Segments:

• By Application :

o Leg
o Chest
o Abdomen
o Arm

• By Disease Indication :

o Chronic Deep Vein Thrombosis
o Post Thrombotic Syndrome
o May-Thurner Syndrome
o Hemodialysis/Arteriovenous Fistulae

• By Technology :

o Iliac Vein Stent Technologies
o Wallstent Technologies

• By Region :

o North America
o Latin America
o Europe
o East Asia
o South Asia & Oceania
o MEA

Questionnaire answered in the report include:
• How the industry has grown?
• What is the present and future outlook on the basis of region?
• What are the challenges and opportunities?
• Why the consumption in region?
• In which year segment is expected to overtake segment?

Explore Fact.MR's More Insights on the Healthcare Domain

Skincare Device Market: https://www.prnewswire.com/news-releases/sales-of-skincare-devices-to-surpass-uss-43-48-bn-as-prevalence-of-dermatological-diseases-increases-factmr-report-301506974.html

ENT Medical Devices Market: https://www.prnewswire.com/news-releases/ear-nose-throat-ent-medical-devices-manufacturers-target-applications-in-cataract--glaucoma-treatment-factmr-301262063.html

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of industry research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.